Redsense receives TGA approval and market authorization for Australia and New Zealand
Redsense Medical today announces that the Therapeutic Goods Administration (TGA) has granted regulatory approval for the Redsense System. Redsense’s blood loss alarm is thus authorized to be sold in the Australian and New Zealand markets. Redsense’s distributor will commence the introduction of the Redsense System in clinics as soon as the prevailing situation allows visits to perform demonstration tests. Considering Australia’s geographic extent, the Company also considers the country a key market for the future introduction of the Redsense Clamp accessory, which will increase patient